Cytotoxicity of methoctramine and methoctramine-related polyamines

Chemico-Biological Interactions

Volumn 181, Issue 3, 2009, Pages 409-416

  Zini, Maddalena ^a   Passariello, Catherine L ^a   Gottardi, Davide ^a   Cetrullo, Silvia ^a   Flamigni, Flavio ^a   Pignatti, Carla ^a   Minarini, Anna ^a   Tumiatti, Vincenzo ^a   Milelli, Andrea ^a   Melchiorre, Carlo ^a   Stefanelli, Claudio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Cell death; Methoctramine; Polyamine analogues; Polyamines

Indexed keywords

ACETYLCYSTEINE; ACYLTRANSFERASE; CASPASE; DIZOCILPINE; HYDROGEN PEROXIDE; METHOCTRAMINE; METHOCTRAMINE DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; ORNITHINE DECARBOXYLASE; POLYAMINE; PROTEIN P53; SPERMIDINE N ACETYLTRANSFERASE; SPERMINE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CELL DEATH; CELL STRAIN HL 60; CHEMICAL MODIFICATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DNA BINDING; DRUG STRUCTURE; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; OXIDATIVE STRESS; POLYAMINE METABOLISM; PROTEIN EXPRESSION; STRUCTURE ACTIVITY RELATION;

BLOTTING, WESTERN; CELL DEATH; CELL LINE, TUMOR; DIAMINES; HUMANS; POLYAMINES;

EID: 70249111805     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2009.06.015     Document Type: Article

References (35)

1. Casero Jr. R.A., and Marton L.J. Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases. Nat. Rev. Drug Discov. 6 (2007) 373-390
2. Bachrach U. Naturally occurring polyamines: interaction with macromolecules. Curr. Protein Pept. Sci. 6 (2005) 559-566
3. Williams K. Modulation and block of ion channels: a new biology of polyamines. Cell Signal. 9 (1997) 1-13
4. Bolognesi M.L., Minarini A., Budriesi R., Cacciaguerra S., Chiarini A., Spampinato S., Tumiatti V., and Melchiorre C. Universal template approach to drug design: polyamines as selective muscarinic receptor antagonists. J. Med. Chem. 41 (1998) 4150-4160
5. Melchiorre C., Antonello A., Banzi R., Bolognesi M.L., Minarini A., Rosini M., and Tumiatti V. Polymethylene tetraamine backbone as template for the development of biologically active polyamines. Med. Res. Rev. 23 (2003) 200-233
6. Melchiorre C., Minarini A., Quaglia W., and Tumiatti V. Methoctramine. Drug Future 14 (1989) 628-631
7. Melchiorre C., Minarini A., Angeli P., Giardinà D., Gulini U., and Quaglia W. Polymethylenetetraamines as muscarinic receptor probes. Trends Pharmacol. Sci. 10 Suppl. (1989) 55-59
8. Melchiorre C., Bolognesi M.L., Budriesi R., Ghelardini C., Chiarini A., Minarini A., Rosini M., Tumiatti V., and Wade E.J. Design, synthesis, and biological activity of methoctramine-related polyamines as putative Gi protein activators. J. Med. Chem. 44 (2001) 4035-4038
9. Rosini M., Budriesi R., Bixel M.G., Bolognesi M.L., Chiarini A., Hucho F., Krogsgaard-Larsen P., Mellor I., Minarini A., Tumiatti V., Usherwood P., and Melchiorre C. Design, synthesis and biological evaluation of symmetrically and unsymmetrically substituted methoctramine-related polyamines as muscular nicotinic receptor noncompetitive antagonists. J. Med. Chem. 42 (1999) 5212-5223
10. Mellor R., Ogilvie J., Pluteanu F., Clothier R., Rosini M., Minarini A., Tumiatti V., and Melchiorre C. Methoctramine analogues inhibit responses to capsaicin and protons in rat dorsal root ganglion neurons. Eur. J. Pharmacol. 505 (2004) 37-50
11. Seiler N. Pharmacological aspects of cytotoxic polyamine analogs and derivatives for cancer therapy. Pharmacol. Ther. 107 (2005) 99-119
12. Minarini A., Quaglia W., Tumiatti V., and Melchiorre C. An improved synthesis of N,N′-bis [6-[[(2-methoxyphenyl) methyl] amino] hexyl]-1,8 octanediamine (methoctramine). Chem. Ind. 19 (1989) 652-653
13. 2 muscarinic receptor blocking activity. Farmaco 46 (1991) 1167-1178
14. Tantini B., Fiumana E., Cetrullo S., Pignatti C., Bonavita F., Shantz L.M., Giordano E., Muscari C., Flamigni F., Guarnieri C., Stefanelli C., and Caldarera C.M. Involvement of polyamines in apoptosis of cardiac myoblasts in a model of simulated ischemia. J. Mol. Cell. Cardiol. 40 (2006) 775-782
15. 11-diethylnorspermine can induce chondrocyte apoptosis independently of its ability to alter metabolism and levels of natural polyamines. J. Cell Physiol. 219 (2009) 109-116
16. Muscari C., Bonafé F., Stanic I., Flamigni F., Stefanelli C., Farruggia G., Guarnieri C., and Caldarera C.M. Polyamine depletion reduces TNFalpha/MG132-induced apoptosis in bone marrow stromal cells. Stem Cells 23 (2005) 983-991
17. Wang Y., Devereux W., Woster P.M., Stewart T.M., Hacker A., and Casero Jr. R.A. Cloning and characterization of a human polyamine oxidase that is inducible by polyamine analogue exposure. Cancer Res. 61 (2001) 5370-5373
18. Stefanelli C., Bonavita F., Stanic' I., Mignani M., Facchini A., Pignatti C., Flamigni F., and Caldarera C.M. Spermine causes caspase activation in leukaemia cells. FEBS Lett. 437 (1998) 233-236
19. Morgan A.R., Lee J.S., Pulleyblank D.E., Murray N.L., and Evans D.H. Ethidium fluorescence assays. Part 1. Physicochemical studies. Nucleic Acids Res. 7 (1979) 547-569
20. McConnaughie A.W., and Jenkins T.C. Novel acridine-triazenes as prototype combilexins: synthesis, DNA binding, and biological activity. J. Med. Chem. 38 (1995) 3488-3501
21. Lavrik I.N., Golks A., and Krammer P.H. Caspases: pharmacological manipulation of cell death. J. Clin. Invest. 115 (2005) 2665-2672
22. 11-diethylnorspermine-induced polyamine pool reduction. Biochem. Soc. Trans. 35 (2007) 405-409
23. Robertson J.D., Orrenius S., and Zhivotovsky B. Nuclear events in apoptosis. J. Struct. Biol. 129 (2000) 346-358
24. Gerner E.W., and Meyskens Jr. F.L. Polyamines and cancer: old molecules, new understanding. Nat. Rev. Cancer 4 (2004) 781-792
25. 1-acetyltransferase in MALME-3M human melanoma cells. J. Biol. Chem. 268 (1993) 19118-19125
26. Boutahar N., Reynaud E., Lassabliere F., and Borg J. Timing differences of signaling response in neuron cultures activated by glutamate analogue or free radicals. Brain Res. 1191 (2008) 20-29
27. Mitchell J.L.A., Thane T.K., Sequeira J.M., and Thokala R. Unusual aspects of the polyamine transport system affect the design of strategies for use of polyamine analogues in chemotherapy. Biochem. Soc. Trans. 35 (2007) 318-321
28. Davis R.H., and Ristow J.L. Uptake, intracellular binding, and excretion of polyamines during growth of Neurospora crassa. Arch. Biochem. Biophys. 271 (1989) 315-322
29. Golstein P., and Kroemer G. Cell death by necrosis: towards a molecular definition. Trends Biochem. Sci. 32 (2007) 37-43
30. Tait S.W., and Green D.R. Caspase-independent cell death: leaving the set without the final cut. Oncogene 27 (2008) 6452-6461
31. Wallace H.M., and Niiranen K. Polyamine analogues-an update. Amino Acids 33 (2007) 261-265
32. Gao X., Xu X., Pang J., Zhang C., Ding J.M., Peng X., Liu Y., and Cao J.M. NMDA receptor activation induces mitochondrial dysfunction, oxidative stress and apoptosis in cultured neonatal rat cardiomyocytes. Physiol. Res. 56 (2007) 559-569
33. Wang J.Q., Tang Q., Parelkar N.K., Liu Z., Samdani S., Choe E.S., Yang L., and Mao L. Glutamate signaling to Ras-MAPK in striatal neurons: mechanisms for inducible gene expression and plasticity. Mol. Neurobiol. 29 (2004) 1-14
34. McInnis J., Wang C., Anastasio N., Hultman M., Ye Y., Salvemini D., and Johnson K.M. The role of superoxide and nuclear factor-kappaB signaling in N-methyl-d-aspartate-induced necrosis and apoptosis. J. Pharmacol. Exp. Ther. 301 (2002) 478-487
35. 2 in polyamine analogue-treated human breast cancer cell lines. J. Biol. Chem. 280 (2005) 39843-39851